Which phase, which therapeutic area, which technologies, what is the right study design, how do we scale, what are the cost implications and which countries should I target?

TORONTO (PRWEB)
November 12, 2021

More sponsors and CROs are seeking to conduct decentralized clinical trials (DCTs) than ever before. Which phase, which therapeutic area, which technologies, what is the right study design, how do we scale, what are the cost implications and which countries should I target? The answers to these questions not only require a strong technology platform, but also require the right consulting expertise to guide implementation strategy.

Research organizations are now embracing the potential of DCTs to take advantage of their potential advantages, such as higher patient engagement, optimized study enrollment and patient retention. Join IDC’s Vice President of Life Sciences R&D Strategy and Technology, Dr. Nimita Limaye, and THREAD’s CEO John Reites in a live webinar on Friday, December 3 2021 at 11am EST (4pm GMT/UK) as they discuss “how” to win with the strategic implementation of DCTs.

For more information, or to register for this event, visit Decentralized Clinical Trials: An Industry Approach for Optimizing Study Design & Driving ROI.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: